Format

Send to

Choose Destination
J Neurochem. 2003 Apr;85(2):476-82.

CAT2 arginine transporter deficiency significantly reduces iNOS-mediated NO production in astrocytes.

Author information

1
Biomedical Sciences Graduate Program, Cancer Center and Department of Medicine, University of California San Diego, La Jolla, California 92093, USA. cmanner@uscd.edu

Abstract

We have previously demonstrated that genetic ablation of cationic amino acid transporter 2 (Cat2) significantly inhibits nitric oxide (NO) production by inducible nitric oxide synthase (iNOS) in activated macrophages. Here we report that iNOS activity is impaired by 84% in activated Cat2-deficient astrocytes. Cat2 ablation appears to reduce astrocyte NO synthesis by decreasing the uptake of the sole precursor, arginine, as well as by reducing the expression of iNOS following activation. Excessive or dysregulated NO production by activated astrocytes and other CNS cell types has been implicated in the pathogenesis of neurological disorders. Our results support the idea that manipulation of CAT2 transporter function might be useful for the therapeutic modulation of iNOS activity.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center